EMIR: Difference between revisions
imported>Martin ODonovan (Further refinements to page additions) |
imported>Modonovan (Change external link into named hyperlink) |
||
| Line 15: | Line 15: | ||
==External links== | ==External links== | ||
ACT briefing note: European regulation of OTC derivatives: Implications for non-financial companies | [http://www.treasurers.org/otc ACT briefing note: European regulation of OTC derivatives: Implications for non-financial companies ] | ||
==References== | ==References== | ||
<references /> | <references /> | ||
Revision as of 11:26, 16 July 2013
European Market Infrastructure Regulation[1] (EMIR) came into force as binding law within the European Union on 16th August 2012, although certain of its requirements came into force after a period of delay.
The objective of EMIR is to reduce the risks posed to financial systems from the vast web of Over the counter (OTC) derivative transactions and the contingent large credit exposures that may arise as a consequence. The Regulation achieves this object by three significant requirements for:
• Central clearing and margining of standardised OTC derivatives (with certain exemptions for Non-Financial Counterparties)
• Reporting of all derivative transactions to a trade repository
• Risk mitigation measures for all non cleared derivatives including collateral exchange and confirmation and reconciliation procedures
See also
External links
ACT briefing note: European regulation of OTC derivatives: Implications for non-financial companies
